𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma

✍ Scribed by Hamblin, T.J.; Inzani, V.; Sadullah, S.; Stevenson, F.K.; Williamson, P.; van der Plas, J.; Palmer, P.; Franks, C.R.

Book ID
122560539
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
310 KB
Volume
16
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of chemotherapy of meta
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin
✍ Robert P. Whitehead; Thomas R. Fleming; John S. Macdonald; Frederick R. Ahmann; πŸ“‚ Article πŸ“… 1991 πŸ› Springer US 🌐 English βš– 205 KB

The combination of 5-fluorouracil and cisplatin has shown encouraging results in single institution pilot studies in colorectal carcinoma. This phase II SWOG study was undertaken to further evaluate this treatment. Cisplatin was administered at a dose of 60 mg/M2 IV day 1, repeated every 21 days. 5-

Phase I trial of subcutaneous recombinan
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou